Sensitivity analysis of FDA´s benchmark nozzle regarding in vitro imperfections - Do we need asymmetric CFD benchmarks?
Modern technologies and methods such as computer simulation, so-called in silico methods, foster the development of medical devices. For accelerating the uptake of computer simulations and to increase credibility and reliability the U.S. Food and Drug Administration organized an inter-laboratory rou...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2020-09-01
|
Series: | Current Directions in Biomedical Engineering |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/cdbme.2020.6.issue-3/cdbme-2020-3020/cdbme-2020-3020.xml?format=INT |